Benchmark Holdings logo

BMK - Benchmark Holdings Share Price

62p 1.5  2.5%

Last Trade - 17/05/21

Mid Cap
Market Cap £415.5m
Enterprise Value £459.4m
Revenue £105.6m
Position in Universe 641st / 1824
Unlock BMK Revenue
Relative Strength (%)
1m -4.98%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -8.82%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Sep 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
44.2 109.4 140.2 131.6 124 105.6 123.9 150.9 +19.0%
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 30 September 2020,Benchmark Holdings PLC revenues decreased 15% to £105.6M.Net loss before extraordinary items decreased 60% to£23.7M. Revenues reflect Advanced Animal Nutrition segmentdecrease of 23% to £59.4M, Animal Health segment decreaseof 39% to £10.8M, All other segments decrease of 42% to£9.3M. Lower net loss reflects Advanced Animal Nutritionsegment loss decrease of 77% to £11.3M.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for BMK
Graphical History


BMK Revenue Unlock BMK Revenue

Net Income

BMK Net Income Unlock BMK Revenue

Normalised EPS

BMK Normalised EPS Unlock BMK Revenue

PE Ratio Range

BMK PE Ratio Range Unlock BMK Revenue

Dividend Yield Range

BMK Dividend Yield Range Unlock BMK Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
BMK EPS Forecasts Unlock BMK Revenue
Profile Summary

Benchmark Holdings plc is engaged in the provision of aquaculture health, genetics and nutrition. The Company’s segments include genetics, advanced nutrition and health. The Company develops products that helps fish and shrimp to improve their sustainability and profitability by improving yield, quality, and by reducing mortality. The Company’s products include high genetic quality ova for salmon, shrimp and tilapia, and breeding, program, specialist feeds for early stage shrimp and fish; probiotics, biocides and medicines.

Last Annual September 30th, 2020
Last Interim September 30th, 2020
Incorporated November 28, 2000
Public Since December 18, 2013
No. of Shareholders: n/a
No. of Employees: 815
Sector Healthcare
Industry Pharmaceuticals
Index FTSE Aim All Share , FTSE Aim 100 ,
Exchange London Stock Exchange (AIM)
Shares in Issue 670,151,034
Free Float (0.0%)
Eligible for
BMK Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for BMK
Upcoming Events for BMK
Tuesday 18th May, 2021
Q2 2021 Benchmark Holdings PLC Earnings Release
Tuesday 18th May, 2021
Q2 2021 Benchmark Holdings PLC Earnings Call for analysts and institutional investors
Tuesday 18th May, 2021
Q2 2021 Benchmark Holdings PLC Earnings Call retail investors
Frequently Asked Questions for Benchmark Holdings
What is the Benchmark Holdings share price?

As of 17/05/21, shares in Benchmark Holdings are trading at 62p, giving the company a market capitalisation of £415.5m. This share price information is delayed by 15 minutes.

How has the Benchmark Holdings share price performed this year?

Shares in Benchmark Holdings are currently trading at 62p and the price has moved by 0.110k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Benchmark Holdings price has moved by 73.93% over the past year.

What are the analyst and broker recommendations for Benchmark Holdings?

Of the analysts with advisory recommendations for Benchmark Holdings, there are there are currently 2 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Benchmark Holdings is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Benchmark Holdings next release its financial results?

Benchmark Holdings is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-09-30
What is the Benchmark Holdings dividend yield?

Benchmark Holdings does not currently pay a dividend.

Does Benchmark Holdings pay a dividend?

Benchmark Holdings does not currently pay a dividend.

When does Benchmark Holdings next pay dividends?

Benchmark Holdings does not currently pay a dividend.

How do I buy Benchmark Holdings shares?

To buy shares in Benchmark Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Benchmark Holdings?

Shares in Benchmark Holdings are currently trading at 62p, giving the company a market capitalisation of £415.5m.

Where are Benchmark Holdings shares listed? Where are Benchmark Holdings shares listed?

Here are the trading details for Benchmark Holdings:

Country of listing: United Kingdom
Exchange: LSE
Ticker Symbol: BMK
What kind of share is Benchmark Holdings?

Based on an overall assessment of its quality, value and momentum, Benchmark Holdings is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Benchmark Holdings share price forecast 2021?

Shares in Benchmark Holdings are currently priced at 62p. At that level they are trading at 13.44% discount to the analyst consensus target price of 71.63.

Analysts covering Benchmark Holdings currently have a consensus Earnings Per Share (EPS) forecast of -0.00785 for the next financial year.

How can I tell whether the Benchmark Holdings share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Benchmark Holdings. Over the past six months, the relative strength of its shares against the market has been 1.46%. At the current price of 62p, shares in Benchmark Holdings are trading at 14.77% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Benchmark Holdings PE Ratio?

We were not able to find PE ratio data for Benchmark Holdings.

Who are the key directors of Benchmark Holdings?

Benchmark Holdings's management team is headed by:

Susan Searle - NID
John Marshall - OTH
James Banfield - OTH
Athene Blakeman - OTH
Anna Winton - OTH
Kevin Quinn - NID
Yngve Myhre - NID
Jan-Emil Johannessen - OTH
Peter George - NEC
Septima Maguire - CFO
Kristian Eikre - NED
Jennifer Haddouk - SEC
Doerte Laue - DMK
Ivonne Cantu - DIR
Trond Williksen - CEO
Who are the major shareholders of Benchmark Holdings?

Here are the top five shareholders of Benchmark Holdings based on the size of their shareholding:

Ferd AS Investment Advisor
Percentage owned: 25.87% (173.3m shares)
Kverva AS Investment Advisor
Percentage owned: 19.28% (129.2m shares)
JNE Partners LLP Investment Advisor
Percentage owned: 16.65% (111.6m shares)
Lansdowne Partners (UK) LLP Investment Advisor/Hedge Fund
Percentage owned: 6.04% (40.5m shares)
Canaccord Genuity Wealth Management Investment Advisor/Hedge Fund
Percentage owned: 3.56% (23.9m shares)
Similar to BMK
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.